The stock of telehealth company American Well (NYSE: AMWL) probably could have used a visit to the doctor this week.

Following the release of its fourth-quarter and full-year earnings last Wednesday, the company was hit with a clutch of analyst price target cuts in the subsequent trading days. As a result, according to data compiled by S&P Global Market Intelligence, its stock price declined by over 7% over the course of the week.

Not one, not two, but three prognosticators trimmed their targets on American Well over the five business days. And one of the trio downgraded her recommendation on the stock.

Continue reading

Source Fool.com